Completed NA INTERVENTIONAL 2-arm
NCT07058233
Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial
Sponsor: Otsuka Holdings Co., Ltd.
Conditions
Pre-xdr tb Rifampin-Resistant Pulmonary Tuberculosis Tuberculosis Multi Drug Resistant Active
Interventions
Oral nutritional supplementation
Updated 1 time since 2025 Last updated: Jun 30, 2025 Started: Apr 1, 2022 Primary completion: Dec 30, 2022 Completion: Dec 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Pre-xdr tb and Rifampin-Resistant Pulmonary Tuberculosis, this trial is completed. The trial is conducted by Otsuka Holdings Co., Ltd. and has accumulated 1 data snapshot since 2022. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Otsuka Holdings Co., Ltd.
- RSUP Persahabatan
Data source: RSUP Persahabatan
For direct contact, visit the study record on ClinicalTrials.gov .